SHARLEEN GLASS: Open Payments
NPI 1235680398 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$455 in 21 payments from 15 companies in 2025. Trend: 2023 $241 · 2024 $195 · 2025 $455
Food & beverage: $455
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 3 | $78 |
| Merck Sharp & Dohme LLC | 2 | $65 |
| TerSera Therapeutics LLC | 3 | $53 |
| Pharmacosmos Therapeutics Inc. | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
| GENZYME CORPORATION | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Aveo Pharmaceuticals, Inc. | 1 | $21 |
| Astellas Pharma US Inc | 1 | $21 |
Products named: Enhertu, Zoladex, KEYTRUDA, WELIREG, MONOFERRIC, FRUZAQLA, LIBTAYO, WAYRILZ.
Industry payments across NC — which companies pay providers there.
